Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pain drugs
Biotech
Undaunted Vertex closes in on FDA nod for non-opioid pain drug
While other companies gave up on trying to develop a non-opioid pain relief medicine by targeting sodium channel inhibition, Vertex stayed the course.
Kevin Dunleavy
Oct 28, 2024 5:00am
Polyrizon pays $3M for license to SciSparc's CB2R agonist
Aug 19, 2024 5:27am
Levicept's ex-Pfizer drug reduces osteoarthritis pain in ph. 2
Aug 6, 2024 1:00am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am
Latigo raises $135M to catch up to Vertex in chronic pain
Feb 14, 2024 5:00am
Seizure drug mechanism could treat osteoarthritis
Jan 5, 2024 10:22am